Vertex Pharmaceuticals Inc. said Wednesday its experimental cystic fibrosis drug VX-809 met key safety and tolerability goals in a midstage study. The company also said the drug candidate prompted a response in a key protein for patients in the study, though that was not the study's main ...

Gilead Sciences Inc. said Thursday an advisory committee has recommended U.S. approval of the biotechnology company's inhalable cystic fibrosis treatment candidate. The company said the Anti-Infective Drugs Advisory Committee of the Food and Drug Administration recommended that aztreonam be approved. The drug is aimed at treating chronic ...

NEW YORK (Reuters Health) - Children with cystic fibrosis, or CF, often have problems with sleeping, eating and complying with the physiotherapy they need, a new study shows. These problem behaviors "may adversely affect health outcomes in children with CF," Dr. Christopher Richard Ward, of Royal Children's Hospital, Parkville, Australia, and colleagues write in the Archives of Disease in Childhood ...